Adam White's background is in biopharma manufacturing and cell and gene therapy, including work at RoslinCT and earlier manufacturing roles tied to Vertex, and he holds an ASQ Lean Six Sigma Green Belt that reflects a focus on quality and process improvement. Based in the Boston area and trained at MIT Sloan, he brings hands-on experience in things like validation programs and manufacturing scale-up to his work as an investor at Walnut Ventures, giving him a close-up view of how therapies move from the lab to real-world production.